Back

LDL-C target attainment and statin use in patients with ASCVD, familial hypercholesterolaemia, and those otherwise at moderate/high-risk of ASCVD in australian general practice (SCOPE-GP)

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular primary care: taking comorbidities into account Cardiovascular Disease in Primary Care ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mrs Catherine Sciascia

(Australia)

5 More presentations in this session

Presentation thumbnail
Utility of the triglycerides/HDL cholesterol ratio in older adult patients in colombia.
Miss C. Murgueitio Guzman (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Modifiable risk factors and incident cardiovascular events in gout patients
Doctor C. Zhao (CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular emergency in indonesian primary health care (PUSKESMAS): a national multicentre service evaluation study based on ESC guidelines adherence
Mr C. Multazam (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Clinical profile and outcomes of patients with chronic kidney disease on chronic hemodialysis hospitalized for acute coronary syndrome in a tertiary public hospital in the Philippines
Doctor J. Mapili (Manila, PH)
Abstract Slides Video
Presentation thumbnail
Prognostic value of neutrophil-to-lymphocyte ratio and cardiac troponin I in patients with immune checkpoint inhibitors-related myocarditis
Professor T. Liu (Tianjin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular primary care: taking comorbidities into account

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Marked variability in reporting of low-density lipoprotein cholesterol values: a national review of pathology providers in Australia
thumbnail
Congress Presentation
Lp(a) testing and LDL-C levels among australian ASCVD patients in 2022: a cross-sectional study from the advara heartcare network (PREVAIL)
thumbnail
Congress Presentation
Comparing achieved treatment targets of genetically confirmed familial hypercholesterolaemia patients followed by primary versus secondary care. a real-world experience from a tertiary welsh centre.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources